Paper: Development of Inhaled Platelet-based Therapy to Repair Damaged Lungs
Ziru Xu is currently a second-year PhD student at King’s college London. Her supervisors are Professor Ben Forbes, Dr. Simon Pitchford and Dr Magda Swedrowska. She graduated from the Joint College of Queen’s University of Belfast (QUB) and China Medical University (CMU) with First Class Honours in Pharmaceutical Science.
She has lab experiences in different countries. During the undergraduate, she contributed to several projects related to Traditional Chinese Medicine, Metabolic Syndrome, and clinical medication. In 2018, She took part in an international exchange program held by International Federation Medical Students’ Association and visited Federal University of Parana, Brazil. Ziru was also involved in the QUB research project, Comparative study of conventional polymer processing and 3D-printing methods for the manufacture of drug-eluting devices.
Generally, she is interested in lung inflammation and pulmonary delivery of biological drugs. Her PhD project focuses on the development of inhalable platelet-based therapy for acute lung injury treatment. It starts from producing platelet-based bioproducts and explores therapeutical effects on the in-vitro disease model of acute lung injury. The potential for development into an inhaled medicine is also investigated. A publication is now in preparation.